Bluetooth technology firms such as Intel and Philips is about to invent a blood pressure monitor that will have a wireless link facility to a PC or Cell phone. The Bluetooth SIG is planning to go for health-related applications for the consumer communications technology with this development. Moreover, IBM, Intel, Motorola, Nonin Medical, Philips Electronics and Welch Allyn, all set to make a Bluetooth Medical Device Profile. It will endorse the use of Bluetooth technology as a new group of medical and fitness products. There are some Bluetooth medical devices with proprietary technology already in the market. The coming design profile will boost interoperability and propagate the use of the technology. Michael Foley, executive director of the Bluetooth SIG says, Bluetooth technology ideally suites for medical devices. It will provide a better quality of life for patients while reducing the cost of healthcare too.
Here is a new concept of accessing electronic medical record. Havannah seems to be a potential conception to access electronic medical record in coming ten years. It applies movable OLED technology using a 12″ diameter screen in an 8″ body. It is the low power using modular wireless technologies to get patient data at the bedside. The patient, the medical counselors and the nurse to smooth communication of diagnosis and procedures can use Havannah.
The combined technology of computer assisted tomography or CAT scans and positron emission tomography or PET scans may detect the cancer and other diseases easily. Researchers at the University of Pennsylvania showed a new combination of both the scan mechanisms. They termed it as ‘Time of Flight Technology’. Philips Medical Systems launched it. It is being used in many hospitals in different countries. The technology is mainly helpful for obese patients. It helps in the revealing and diagnosis of tumors growth in body. Although, it uses, most of the times, in cancer patients. It may be helpful in the fields of cardiology and neurology.
This new medical device applies quantitative ultrasound technology to count the emboli in the blood stream. A Virginia company, Luna Innovations Inc., has innovated this new device Embolus Detection and Classification Quantifier (EDAC Quantifier) system. The primary release of EDAC Quantifier system is not for medical use. It identifies microemboli at rates up to 1000 per second using advanced ultrasound technology. Emboli may enter the blood stream during invasive medical procedures in the form of air bubble or solid form. It causes neurological disorders and fatalities. The EDAC Quantifier system enumerates the emboli rates in ex-vivo circuits. It might give the readings of time motion representation of individual emboli tracks, emboli rates and growing emboli counts.
The researchers at the University of Alberta in Edmonton have developed a artificial device that allows teeth and bones to re-grow. This device is based on the low-intensity pulsed ultrasound technology. Jie Chen, the nano-circuit design expert says that he is looking to use the device to fix diseased teeth or to replace asymmetric jawbones. The tiny ultrasound device massages gums and fuels tooth growth when inserted into a person’s mouth. This is a wireless device and even shorter than a pea. It should be worked for twenty minutes daily for four months. The continuous process helps the stimulation of teeth growth. It may help to the growth of jawbone and in the long run help people to grow taller by stimulating bone growth.
Rheologics introduced a research device in the year 2001 for measuring the biophysical properties of circulating blood. The ‘Rheolog’ measures the rheological properties of blood in an environment that imitates blood flow in the human vascular system. Dual riser tube technology combined with advanced microprocessors and proprietary algorithms, the innovative scanning capillary viscometer of the device picks up patient’s blood viscosity. The Rheolog enables researchers and doctors to get an accurate blood viscosity profile in no time in the lab. This is the first disposable device of its kind that decreases clean-up and removes the contamination and operational errors. The new beta-version about to be finalized for commercial process.
Researchers at Medical College of Georgia have introduced a new technology to treat the tooth loss due to gum disease, that would embed specialized proteins onto dental implants to stimulate native stem cells to differentiate and become bone-forming cells thereby contributing to bone-regenerating implants. Researchers say: Titanium dental implants coated with proteins that induce bone formation may be a key advancement in treating tooth loss due to gum disease. Dr. Wikesj says: There was almost complete regeneration. The generated bone bonded with the implant’s surface and, eventually, existing bone in the gums. That allowed for the regeneration of gum tissues.
Forgot to take your medicine? Here is the MD.2 Personal Medication System, about the size of a coffee maker that helps patients take their medication regularly. This helps patients take their medication regularly so that it works effectively: The device alerts the caretaker of the patient every time the patient forgets to take medications at proper time. The whole records can be traced out on the internet also. MD.2 Personal Medication System is available for sale on ePill.com.
You must be aware of the Quantun dots that helps to trace out the disease molecule inside cells or body. According to National Cancer Institute’s Alliance for Nanotechnology, Stanford investigators have introduced self-illuminating bright quantum dots, thereby no need for external light source to be visualized. A team under Jianghong Rao, Ph.D., a member of the Stanford CCNE (Center for Cancer Nanotechnology Excellence) developed a method for protein coating over the quantum dots. A molecule called coelenterazine is attached to the quantum dots that produce the bright fluorescent light. The researchers claim that this technology could be utilized to add variant proteins and to chemically label cells also.
The world’s first needle-sized single-rod implantable contraceptive, Implanon, has got the FDA’s thumbs up which would be a news of relief for the women who are longing for a long-term solution to avoid pregnancy. Toon Wilderbeek, Akzo Nobel’s Board member responsible for Pharma said: Implanon is a state-of-the-art contraceptive which further demonstrates Organon’s ongoing commitment to continue its leadership position in gynaecology. We are excited about the FDA’s approval for Implanon, which represents a real advance in contraceptive technology and will provide women with a new level of confidence in contraception. Implanon prevent the ovulation by releasing progestin and it can even help some women get rid of their monthly menses.